Similar articles for PMID: 23059429

Year	Number of Results
1999	1
2004	1
2005	2
2006	3
2007	3
2008	4
2009	7
2010	9
2011	14
2012	16
2013	16
2014	14
2015	11
2016	4
2017	2
2018	2
2019	1
2020	2
2021	3
2022	3
2023	1
2024	0

1

A20: linking a complex regulator of ubiquitylation to immunity and human disease.

Ma A, Malynn BA. Ma A, et al. Nat Rev Immunol. 2012 Nov;12(11):774-85. doi: 10.1038/nri3313. Epub 2012 Oct 12. Nat Rev Immunol. 2012. PMID: 23059429 Free PMC article. Review.

2

The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology.

Vereecke L, Beyaert R, van Loo G. Vereecke L, et al. Trends Immunol. 2009 Aug;30(8):383-91. doi: 10.1016/j.it.2009.05.007. Epub 2009 Jul 28. Trends Immunol. 2009. PMID: 19643665 Review.

3

A20: central gatekeeper in inflammation and immunity.

Coornaert B, Carpentier I, Beyaert R. Coornaert B, et al. J Biol Chem. 2009 Mar 27;284(13):8217-21. doi: 10.1074/jbc.R800032200. Epub 2008 Nov 13. J Biol Chem. 2009. PMID: 19008218 Free PMC article. Review.

4

Downstream activation of NF-κB in the EDA-A1/EDAR signalling in Sjögren's syndrome and its regulation by the ubiquitin-editing enzyme A20.

Sisto M, Barca A, Lofrumento DD, Lisi S. Sisto M, et al. Clin Exp Immunol. 2016 May;184(2):183-96. doi: 10.1111/cei.12764. Epub 2016 Feb 23. Clin Exp Immunol. 2016. PMID: 26724675 Free PMC article.

5

A20: from ubiquitin editing to tumour suppression.

Hymowitz SG, Wertz IE. Hymowitz SG, et al. Nat Rev Cancer. 2010 May;10(5):332-41. doi: 10.1038/nrc2775. Epub 2010 Apr 12. Nat Rev Cancer. 2010. PMID: 20383180 Review.

6

A20 in inflammation and autoimmunity.

Catrysse L, Vereecke L, Beyaert R, van Loo G. Catrysse L, et al. Trends Immunol. 2014 Jan;35(1):22-31. doi: 10.1016/j.it.2013.10.005. Epub 2013 Nov 15. Trends Immunol. 2014. PMID: 24246475 Review.

7

Regulation of NF-κB signaling by the A20 deubiquitinase.

Shembade N, Harhaj EW. Shembade N, et al. Cell Mol Immunol. 2012 Mar;9(2):123-30. doi: 10.1038/cmi.2011.59. Epub 2012 Feb 20. Cell Mol Immunol. 2012. PMID: 22343828 Free PMC article. Review.

8

Expression, biological activities and mechanisms of action of A20 (TNFAIP3).

Verstrepen L, Verhelst K, van Loo G, Carpentier I, Ley SC, Beyaert R. Verstrepen L, et al. Biochem Pharmacol. 2010 Dec 15;80(12):2009-20. doi: 10.1016/j.bcp.2010.06.044. Epub 2010 Jul 3. Biochem Pharmacol. 2010. PMID: 20599425 Review.

9

Single nucleotide polymorphisms at the TNFAIP3/A20 locus and susceptibility/resistance to inflammatory and autoimmune diseases.

Mele A, Cervantes JR, Chien V, Friedman D, Ferran C. Mele A, et al. Adv Exp Med Biol. 2014;809:163-83. doi: 10.1007/978-1-4939-0398-6_10. Adv Exp Med Biol. 2014. PMID: 25302371 Review.

10

Genetic relationships between A20/TNFAIP3, chronic inflammation and autoimmune disease.

Vereecke L, Beyaert R, van Loo G. Vereecke L, et al. Biochem Soc Trans. 2011 Aug;39(4):1086-91. doi: 10.1042/BST0391086. Biochem Soc Trans. 2011. PMID: 21787353 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

103 results

Results by year